Back to Journals » Drug Design, Development and Therapy » Volume 11

A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers

Total article views   Abstract views HTML views PDF downloads Totals
8,952 Dovepress* 7,951 605+ 928 8,556
PubMed Central* 0 396 127 396
Totals 7,951 1,001 1,055 8,952
*Since 24 April 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar